This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barski, G., and Cornefert, F., J. Nat. Cancer Inst., 28, 801 (1962).
Barski, G., Sorieul, S., and Cornefert, F., J. Nat. Cancer Inst., 26, 1269 (1962).
Silagi, S., Cancer Res., 27, 1953 (1967).
Defendi, V., Ephrussi, B., and Koprowski, H., Nature, 203, 495 (1964).
Scaletta, L. J., and Ephrussi, B., Nature, 205, 1169 (1965).
Defendi, V., Ephrussi, B., Koprowski, H., and Yoshida, M. C., Proc. US Nat. Acad. Sci., 57, 299 (1967).
Finch, B. W., and Ephrussi, B., Proc. US Nat. Acad. Sci., 57, 615 (1967).
Harris, H., Miller, O. J., Klein, G., Worst, P., and Tachibana, T., Nature, 223, 363 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
HARRIS, H., KLEIN, G. Malignancy of Somatic Cell Hybrids (reply). Nature 224, 1315–1316 (1969). https://doi.org/10.1038/2241315a0
Received:
Issue Date:
DOI: https://doi.org/10.1038/2241315a0
This article is cited by
-
What history tells us XII. Boris Ephrussi’s continuing efforts to create a “genetics of differentiation”
Journal of Biosciences (2008)
-
The current state of oncogenes and cancer: Experimental approaches for analyzing oncogenetic events in human cancer
CANCER AND METASTASIS REVIEW (1990)
-
Susceptibility forN-ras-mediated transformation requires loss of tumor suppressor activity
Somatic Cell and Molecular Genetics (1990)
-
Is the P388 murine tumor no longer adequate as a drug discovery model?
Investigational New Drugs (1987)
-
Formation of Hybrid Cells and Heterokaryons by Fusion of Enucleated and Nucleated Cells
Nature New Biology (1971)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.